US court says epilepsy patent is valid

15-08-2016

US court says epilepsy patent is valid

Piotr Adamowicz / Shutterstock.com

The US District Court for the District of Delaware has ruled that pharmaceutical company UCB’s patent covering epilepsy drug Vimpat (lacosamide) is valid, after it was challenged by generic drug makers.


Vimpat, UCB, generics, lacosamide,USPTO

LSIPR